Lopez-Cortes LF - Search Results

1

Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients.

Gutierrez-Valencia A, Benmarzouk-Hidalgo OJ, Llaves S, Fernandez-Magdaleno T, Espinosa N, Viciana P, Lopez-Cortes LF. Gutierrez-Valencia A, et al. J Antimicrob Chemother. 2017 Mar 1;72(3):816-819. doi: 10.1093/jac/dkw487. J Antimicrob Chemother. 2017. PMID: 27999051 Free article.

2

Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient.

Caballero-Granado FJ, Viciana P, Cordero E, Gómez-Vera MJ, del Nozal M, López-Cortés LF. Caballero-Granado FJ, et al. Antimicrob Agents Chemother. 1997 May;41(5):1207. doi: 10.1128/AAC.41.5.1207. Antimicrob Agents Chemother. 1997. PMID: 9145904 Free PMC article. No abstract available.

3

Efavirenz plasma concentrations and efficiency.

López-Cortés LF, de Alarcón A, Viciana P. López-Cortés LF, et al. AIDS. 2001 Jun 15;15(9):1192-4. doi: 10.1097/00002030-200106150-00022. AIDS. 2001. PMID: 11416729 No abstract available.

4

Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.

López-Cortés LF, Ruiz-Valderas R, Viciana P, Alarcón-González A, Gómez-Mateos J, León-Jimenez E, Sarasanacenta M, López-Pua Y, Pachón J. López-Cortés LF, et al. Clin Pharmacokinet. 2002;41(9):681-90. doi: 10.2165/00003088-200241090-00004. Clin Pharmacokinet. 2002. PMID: 12126459 Clinical Trial.

5

Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy.

López-Cortés LF, Ruiz-Valderas R, Viciana P, Mata R, Gómez-Vera J, Alarcón A, Pachón J. López-Cortés LF, et al. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):240-2. doi: 10.1097/00126334-200302010-00019. J Acquir Immune Defic Syndr. 2003. PMID: 12571537 Clinical Trial. No abstract available.

6

Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.

Mata RC, Viciana P, de Alarcón A, López-Cortés LF, Gómez-Vera J, Trastoy M, Cisneros JM. Mata RC, et al. AIDS Patient Care STDS. 2005 Sep;19(9):550-62. doi: 10.1089/apc.2005.19.550. AIDS Patient Care STDS. 2005. PMID: 16164382 Clinical Trial.

7

Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients.

Marin-Niebla A, Lopez-Cortes LF, Ruiz-Valderas R, Viciana P, Mata R, Gutierrez A, Pascual R, Rodriguez M. Marin-Niebla A, et al. Antimicrob Agents Chemother. 2007 Jun;51(6):2035-42. doi: 10.1128/AAC.01136-06. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371813 Free PMC article. Clinical Trial.

8

Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.

Lopez-Cortes LF, Ruiz-Valderas R, Rivero A, Camacho A, Marquez-Solero M, Santos J, García-Lazaro M, Viciana P, Rodriguez-Baños J, Ocampo A. Lopez-Cortes LF, et al. Ther Drug Monit. 2007 Apr;29(2):171-6. doi: 10.1097/FTD.0b013e31803bb54e. Ther Drug Monit. 2007. PMID: 17417070

9

Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients.

Mira JA, Valera-Bestard B, Arizcorreta-Yarza A, González-Serrano M, Torre-Cisneros J, Santos I, Vergara S, Gutiérrez-Valencia A, Girón-González JA, Macías J, López-Cortés LF, Pineda JA. Mira JA, et al. Antivir Ther. 2007;12(4):523-9. Antivir Ther. 2007. PMID: 17668561

10

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

Vergara S, Macías J, Rivero A, Gutiérrez-Valencia A, González-Serrano M, Merino D, Ríos MJ, García-García JA, Camacho A, López-Cortés L, Ruiz J, de la Torre J, Viciana P, Pineda JA; Grupo para el Estudio de las Hepatitis Viricas de la SAEI. Vergara S, et al. Clin Infect Dis. 2007 Oct 15;45(8):969-74. doi: 10.1086/521857. Epub 2007 Sep 11. Clin Infect Dis. 2007. PMID: 17879910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters